News
FDA seizes hundreds of fake Ozempic units from US supply after Novo Nordisk alerts regulators to counterfeit semaglutide ...
The former workers cited various reasons why they think Novo was cautious: its conservative culture and history of investing ...
An analysis of pooled data from two large finerenone trials identified key risk factors for hyperkalemia in patients with CKD ...
At ASCO 2025, pharmaphorum web editor Nicole Raleigh sat down to discuss key highlights from the Congress with EVERSANA experts.
Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...
As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...
In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...
Novo Nordisk continues to deliver strong revenue, profit growth, and high economic profitability. Read why I rate NVO stock a ...
8d
Zacks Investment Research on MSNNovo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock Has More Upside?Novo Nordisk NVO and Viking Therapeutics VKTX have emerged as notable players in the obesity space. A market leader in the ...
10d
Zacks Investment Research on MSNHere is What to Know Beyond Why Novo Nordisk A/S (NVO) is a Trending StockNovo Nordisk (NVO) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider ...
Despite Lars Fruergaard Jørgensen's resignation as Novo Nordisk's CEO, its stock price has risen 10% over the past two weeks.
Years before Novo Nordisk's obesity drug Wegovy became a U.S. blockbuster, then-CEO Lars Rebien Sorensen told a press ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results